Updating results

551 results

Sort: Relevance | Date

Electrohydraulic lithotripsy for difficult-to-treat bile duct stones

In development [GID-IPG10151] Expected publication date: TBC

Interventional procedures guidance In development

Transapical transcatheter mitral valve-in-valve implantation for a failed surgically-implanted mitral valve bioprosthesis

In development [GID-IPG10152] Expected publication date: TBC

Interventional procedures guidance In development

Intravascular lithotripsy for calcified coronary arteries during percutaneous coronary intervention

In development [GID-IPG10132] Expected publication date: 18 March 2020

Interventional procedures guidance In development

Cervical ripening ballon for the induction of labour in women who have previously undergone cesarean section

In development [GID-IP1131] Expected publication date: TBC

Interventional procedures guidance In development

Minimally invasive radical hysterectomy for early stage cervical cancer

In development [GID-IPG10131] Expected publication date: 18 March 2020

Interventional procedures guidance In development

Lung transplantation with ex-vivo perfusion

In development [GID-IP1046] Expected publication date: TBC

Interventional procedures guidance In development

Deep brain stimulation for refractory epilepsy

In development [GID-IPG10129] Expected publication date: 20 May 2020

Interventional procedures guidance In development

Transcranial magnetic stimulation for obsessive-compulsive disorder

In development [GID-IPG10134] Expected publication date: 20 May 2020

Interventional procedures guidance In development

High tibial osteotomy with adjustable magnetic nail insertion for symptomatic medial knee osteoarthritis

In development [GID-IPG10142] Expected publication date: TBC

Interventional procedures guidance In development

Maintenance of normo-thermia to improve outcomes following neurological injury

In development [GID-IPG10153] Expected publication date: TBC

Interventional procedures guidance In development

Transcatheter Mitral Valve In Ring (TMVIR) for treating a failing mitral valve repair

In development [GID-IPG10154] Expected publication date: TBC

Interventional procedures guidance In development

Transvaginal laser therapy for urogenital atrophy

In development [GID-IPG10155] Expected publication date: TBC

Interventional procedures guidance In development

Transvaginal laser therapy for stress urinary incontinence

In development [GID-IPG10156] Expected publication date: TBC

Interventional procedures guidance In development

Vagus nerve stimulation for treatment-resistant depression

In development [GID-IPG10133] Expected publication date: 20 May 2020

Interventional procedures guidance In development

Selective internal radiation therapy for unresectable colorectal metastases in the liver

In development [GID-IPG10124] Expected publication date: 04 March 2020

Interventional procedures guidance In development

MRI-guided laser interstitial thermal therapy for drug-resistant epilepsy

In development [GID-IPG10122] Expected publication date: 04 March 2020

Interventional procedures guidance In development

Cyanoacrylate glue occlusion for varicose veins

In development [GID-IPG10128] Expected publication date: 04 March 2020

Interventional procedures guidance In development

Bilateral cervicosacropexy or vaginosacropexy using mesh for pelvic organ prolapse

In development [GID-IPG10123] Expected publication date: 04 March 2020

Interventional procedures guidance In development

Artificial iris insertion for acquired aniridia

In development [GID-IPG10130] Expected publication date: 22 April 2020

Interventional procedures guidance In development

Artificial iris insertion for congenital aniridia

In development [GID-IPG10144] Expected publication date: 22 April 2020

Interventional procedures guidance In development

Listeria monocytogenes vaccine for previously treated malignant pleural mesothelioma ID1353

In development [GID-TA10320] Expected publication date: TBC

Technology appraisal guidance In development

Dasatinib for treating Philadelphia-chromosome-positive acute lymphoblastic leukaemia in children and adults ID1297

In development [GID-TA10311] Expected publication date: TBC

Technology appraisal guidance In development

Durvalumab for untreated PD-L1 positive metastatic urothelial bladder cancer ID1169

In development [GID-TA10324] Expected publication date: TBC

Technology appraisal guidance In development

Entinostat for treating hormone receptor-positive breast cancer after hormonal therapy ID1260

In development [GID-TA10309] Expected publication date: TBC

Technology appraisal guidance In development

Glasdegib with chemotherapy for untreated acute myeloid leukaemia [ID1334]

In development [GID-TA10314] Expected publication date: TBC

Technology appraisal guidance In development

Depatuxizumab mafodotin in combination for untreated EGFR-amplified glioblastoma ID1466

In development [GID-TA10355] Expected publication date: TBC

Technology appraisal guidance In development

Empagliflozin for type 1 Diabetes Mellitus, adjunct to insulin ID1275

In development [GID-TA10375] Expected publication date: TBC

Technology appraisal guidance In development

Ixazomib with lenalidomide and dexamethasone for untreated multiple myeloma [ID1170]

In development [GID-TA10254] Expected publication date: TBC

Technology appraisal guidance In development

Cardiac transplantation (rejection) - everolimus [ID114]

In development [GID-TAG232] Expected publication date: TBC

Technology appraisal guidance In development

Non-bisphosphonates for treating osteoporosis [ID901]

In development [GID-TA10072] Expected publication date: TBC

Technology appraisal guidance In development

Spasticity (after stroke) - botulinum toxin type A [ID768]

In development [GID-TAG499] Expected publication date: TBC

Technology appraisal guidance In development

Ibrutinib for untreated mantle cell lymphoma (ID1221)

In development [GID-TA10185] Expected publication date: TBC

Technology appraisal guidance In development

Furosemide micro-pump for treating oedema associated with heart failure (ID1061)

In development [GID-TA10179] Expected publication date: TBC

Technology appraisal guidance In development

NY-ESO-1 T-cells for treating synovial sarcoma ID1286

In development [GID-TA10205] Expected publication date: TBC

Technology appraisal guidance In development

ATA129 for treating post-transplant lymphoproliferative disorder caused by the Epstein-Barr virus ID1203

In development [GID-TA10204] Expected publication date: TBC

Technology appraisal guidance In development

Ibrutinib for treating relapsed or refractory follicular lymphoma [1251]

In development [GID-TA10223] Expected publication date: TBC

Technology appraisal guidance In development

Asunercept for treating glioblastoma [1301]

In development [GID-TA10227] Expected publication date: TBC

Technology appraisal guidance In development

Cimavax for treating wild-type EGFR-positive non-small-cell lung cancer [1259]

In development [GID-TA10225] Expected publication date: TBC

Technology appraisal guidance In development

Avelumab for treating gastric or gastro-oesophageal junction cancer after 2 therapies ID1289

In development [GID-TA10210] Expected publication date: TBC

Technology appraisal guidance In development

Pembrolizumab for previously treated metastatic gastric or gastro-oesophageal junction cancer ID1168

In development [GID-TA10208] Expected publication date: TBC

Technology appraisal guidance In development

Selumetinib for treating differentiated thyroid cancer ID1079

In development [GID-TA10207] Expected publication date: TBC

Technology appraisal guidance In development

Duvelisib for treating relapsed follicular lymphoma after 2 systemic therapies [ID1090]

In development [GID-TA10209] Expected publication date: TBC

Technology appraisal guidance In development

Venetoclax with obinutuzumab for untreated chronic lymphocytic leukaemia [ID1402]

In development [GID-TA10328] Expected publication date: TBC

Technology appraisal guidance In development

Galcanezumab for preventing migraine [ID1372]

In development [GID-TA10454] Expected publication date: 14 October 2020

Technology appraisal guidance In development

Nivolumab for untreated advanced hepatocellular carcinoma [ID1248]

In development [GID-TA10221] Expected publication date: TBC

Technology appraisal guidance In development

Brolucizumab for treating wet age-related macular degeneration [ID1254]

In development [GID-TA10455] Expected publication date: TBC

Technology appraisal guidance In development

Obinutuzumab with bendamustine for treating follicular lymphoma refractory to rituximab [ID1583]

In development [GID-TA10530] Expected publication date: 13 May 2020

Technology appraisal guidance In development

Anakinra for treating active Stills disease [ID1463]

In development [GID-TA10392] Expected publication date: 26 June 2020

Technology appraisal guidance In development

Nivolumab with ipilimumab and chemotherapy for untreated advanced non-small-cell lung cancer [ID1566]

In development [GID-TA10472] Expected publication date: TBC

Technology appraisal guidance In development

Idasanutlin with cytarabine for treating relapsed or refractory acute myeloid leukaemia [ID1597]

In development [GID-TA10494] Expected publication date: TBC

Technology appraisal guidance In development